kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the GANX dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for GANX.

GANX

Gain Therapeutics, Inc.
Healthcare · Biotechnology
$63.30 sample
-0.42 (-0.66%) 1D
☆ Watch
Market cap
$172.8B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-05
Alerts
8
Price$63.30 -0.46% 3M daily closessample
66.5262.76
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 26INSInsider buy: Chief Executive Officer
  • Oct 19INSInsider sell: EVP, Operations
  • Oct 12INSInsider buy: EVP, Operations
  • Oct 05SEC8-K filed: material event
  • Sep 29SECDEF 14A filed
  • Sep 23INSInsider sell: EVP, Operations
  • Sep 18INSInsider buy: 10% owner
  • Sep 10INSInsider sell: Chief Financial Officer
Sign up to see the real GANX record →

Company facts

SEC EDGAR registration
Name
Gain Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-7sample, -100 to +100
Reporting currency
USD

Who is positioning in GANX

sample
Insiders
15 insider transactions over 90 days, net selling, $654.8M
Congress
No member trades over 90 days
Institutions · 13F
10 funds hold $2.6B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$4.8B +22.5% y/y
Q4 2024Q3 2026
Inventory$2.8B +14.1% y/y
Q4 2024Q3 2026
Accounts receivable$2.1B +14.5% y/y
Q4 2024Q3 2026
Total debt$5.5B +14.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$26.3B -10.8% 3M
Sample peer B
$162.6B +13.0% 3M
Sample peer C
$41.0B -7.5% 3M
Sample peer D
$97.7B +5.8% 3M
Sample peer E
$63.1B -7.1% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not GANX's real figure. Nothing here is investment advice.